Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Glutinol inhibits the proliferation of human ovarian cancer cells via PI3K/AKT signaling pathway

Yuanyuan Chen¹, Juan Li²

¹Department of Radiation Oncology, Women’s Hospital; ²Department of Radiation Oncology, Affiliated Hangzhou Cancer Hospital, School of Medicine, Zhejiang University, HangZhou, ZheJiang 310002, China.

For correspondence:- Juan Li Email: jlu.edu.1@gmail.com Tel:+8657156006302

Accepted: 24 June 2021 Published: 29 July 2021

Citation: Chen Y, Li J. Glutinol inhibits the proliferation of human ovarian cancer cells via PI3K/AKT signaling pathway. Trop J Pharm Res 2021; 20(7):1331-1335 doi: 10.4314/tjpr.v20i7.2

© 2021 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the anticancer effect of glutinol on OVACAR3 human ovarian cancer cells, and to elucidate the underlying molecular mechanisms.

Methods: Cell viability was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Cell cycle distribution, reactive oxygen species (ROS) and mitochondrial membrane potential were measured via flow cytometry, while protein expression levels were determined with western blotting assay.

Results: Glutinol exerted significant growth-inhibitory effects on human OVACAR3 cells, but interestingly, it exhibited comparatively lower cytotoxic effects against normal SV40 cells. The IC₅₀ of glutinol against human OVACAR3 cells was 6 µM, while the IC₅₀ against normal SV40 cells was 60 µM. Flow cytometric analysis showed an increase in population of OVACAR3 cells in G2/M phase from 4.02 % in control to 29.05 % on treatment with 12 µM glutinol, suggestive of G2/M phase arrest. The G2/M arrest of OVACAR3 cells was also accompanied by suppression of cyclin B1. It was also found that increases in ROS levels and decreases in MMP activities contributed to the glutinol-induced antiproliferative effects on human OVACAR3 cells. Moreover, glutinol deactivated the PI3K/AKT signaling pathway in OVACAR-3 ovarian cancer cells.

Conclusion: Glutinol exerted potent anticancer effects against human ovarian cancer. Thus, it might be of potential benefit in the treatment of ovarian cancer.

Keywords: Ovarian cancer, Glutinol, Cell cycle arrest, Chemotherapy, Triterpenes